logo

Cortexyme Inc (CRTX)



Trade CRTX now with
  Date
  Headline
3/17/2020 8:08:40 AM Cortexyme Posts Q4 Net Loss Of $12.4 Mln Or $0.46 Per Basic Share
3/16/2020 8:24:53 AM Cortexyme Says GAIN Trial In Alzheimer's Disease Reaches Enrollment Milestone Of 300 Patients
2/14/2020 12:14:20 PM Stock To Watch: Cortexyme (CRTX)
1/13/2020 8:10:19 AM Cortexyme Initiates Open-Label Extension Study For GAIN Trial Of COR388 In Alzheimer's Disease
6/19/2019 8:20:01 AM Cortexyme Adds Jeffrey Cummings, David Hosford, Lon Schneider And Pierre Tariot To Clinical Advisory Board
5/8/2019 10:01:41 PM Cortexyme Prices IPO Of 4.41 Mln Shares At $17.00/shr